Results 31 to 40 of about 4,080,709 (367)

Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia.

open access: yesJournal of the American Society of Nephrology, 2020
BACKGROUND Some patients with COVID-19 pneumonia also present with kidney injury, and autopsy findings of patients who died from the illness sometimes show renal damage.
Guangchang Pei   +11 more
semanticscholar   +1 more source

Ionized hypercalcemia in cats with azotemic chronic kidney disease (2012‐2018)

open access: yesJournal of Veterinary Internal Medicine, 2022
Background Hypercalcemia is associated with chronic kidney disease (CKD) in cats, but studies assessing the physiologically relevant ionized calcium fraction are lacking.
Dirk Hendrik Nicolaas van denBroek   +5 more
doaj   +1 more source

Diffuse thyroid metastases and bilateral internal jugular vein tumor thrombus from renal cell cancer. [PDF]

open access: yes, 2016
Renal cell cancer rarely metastasizes to the thyroid gland, and it has been reported to present as a solitary mass. We present a case of diffuse thyroid cancer metastases from renal cell cancer.
Jha, Priyanka   +3 more
core   +1 more source

Avelumab plus Axitinib versus Sunitinib for Advanced Renal‐Cell Carcinoma

open access: yesNew England Journal of Medicine, 2019
BACKGROUND In a single‐group, phase 1b trial, avelumab plus axitinib resulted in objective responses in patients with advanced renal‐cell carcinoma. This phase 3 trial involving previously untreated patients with advanced renal‐cell carcinoma compared ...
R. Motzer   +27 more
semanticscholar   +1 more source

Renal fibrosis in feline chronic kidney disease: known mediators and mechanisms of injury [PDF]

open access: yes, 2015
Chronic kidney disease (CKD) is a common medical condition of ageing cats. In most cases the underlying aetiology is unknown, but the most frequently reported pathological diagnosis is renal tubulointerstitial fibrosis.
Elliott, J   +4 more
core   +1 more source

Sorafenib in advanced clear-cell renal-cell carcinoma.

open access: yesNew England Journal of Medicine, 2007
BACKGROUND We conducted a phase 3, randomized, double-blind, placebo-controlled trial of sorafenib, a multikinase inhibitor of tumor-cell proliferation and angiogenesis, in patients with advanced clear-cell renal-cell carcinoma.
B. Escudier   +18 more
semanticscholar   +1 more source

Epidemiology of Renal Cell Carcinoma

open access: yesWorld Journal of Oncology, 2020
Though renal cell carcinoma (RCC) accounts for 2% of global cancer diagnoses and deaths, it has more than doubled in incidence in the developed world over the past half-century, and today is the ninth most common neoplasm in the United States (US). While
S. Padala   +7 more
semanticscholar   +1 more source

Renal osteodystrophy presenting predominantly with osteosclerosis

open access: yesSahel Medical Journal, 2015
Renal osteodystrophy is a skeletal pathology characterized by bone mineralization deficiency, which is a direct result of endocrine and electrolyte derangements that accompany chronic kidney disease.
Oriazo Theophilus Akhigbe   +1 more
doaj   +1 more source

Applicability of B-mode ultrasonography, ARFI elastography and contrast-enhanced ultrasound in the evaluation of chronic kidney disease in dogs [PDF]

open access: yesPesquisa Veterinária Brasileira, 2021
: The objective of this study was to verify the applicability of B-mode ultrasonography, ARFI elastography and CEUS in the diagnosis of chronic kidney disease and its Stages in dogs. 24 healthy dogs and 28 with CKD were included.
Igor C.K. da Cruz   +7 more
doaj   +1 more source

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

open access: yesNew England Journal of Medicine, 2001
BACKGROUND Diabetic nephropathy is the leading cause of end-stage renal disease. Interruption of the renin-angiotensin system slows the progression of renal disease in patients with type 1 diabetes, but similar data are not available for patients with ...
B. Brenner   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy